Literature DB >> 19908332

Experimental evidence of obesity as a risk factor for severe acute pancreatitis.

Jean-Louis Frossard, Pierre Lescuyer, Catherine M Pastor.   

Abstract

The incidence of acute pancreatitis, an inflammation of the pancreas, is increasing worldwide. Pancreatic injury is mild in 80%-90% of patients who recover without complications. The remaining patients may develop a severe disease with local complications such as acinar cell necrosis, abscess and remote organ injury including lung injury. The early prediction of the severity of the disease is an important goal for physicians in management of patients with acute pancreatitis in order to optimize the therapy and to prevent organ dysfunction and local complications. For that purpose, multiple clinical scale scores have been applied to patients with acute pancreatitis. Recently, a new problem has emerged: the increased severity of the disease in obese patients. However, the mechanisms by which obesity increases the severity of acute pancreatitis are unclear. Several hypotheses have been suggested: (1) obese patients have an increased inflammation within the pancreas; (2) obese patients have an increased accumulation of fat within and around the pancreas where necrosis is often located; (3) increase in both peri- and intra-pancreatic fat and inflammatory cells explain the high incidence of pancreatic inflammation and necrosis in obese patients; (4) hepatic dysfunction associated with obesity might enhance the systemic inflammatory response by altering the detoxification of inflammatory mediators; and (5) ventilation/perfusion mismatch leading to hypoxia associated with a low pancreatic flow might reduce the pancreatic oxygenation and further enhance pancreatic injury. Recent experimental investigations also show an increased mortality and morbidity in obese rodents with acute pancreatitis and the implication of the adipokines leptin and adiponectin. Such models are important to investigate whether the inflammatory response of the disease is enhanced by obesity. It is exciting to speculate that manipulation of the adipokine milieu has the potential to influence the severity of acute pancreatitis.

Entities:  

Mesh:

Year:  2009        PMID: 19908332      PMCID: PMC2776851          DOI: 10.3748/wjg.15.5260

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  53 in total

Review 1.  New serum markers for the detection of severe acute pancreatitis in humans.

Authors:  J L Frossard; A Hadengue; C M Pastor
Journal:  Am J Respir Crit Care Med       Date:  2001-07-01       Impact factor: 21.405

2.  Increased body weight as a prognostic parameter for complications in the course of acute pancreatitis.

Authors:  P G Lankisch; C A Schirren
Journal:  Pancreas       Date:  1990-09       Impact factor: 3.327

3.  Obesity increases the severity of acute pancreatitis: performance of APACHE-O score and correlation with the inflammatory response.

Authors:  Georgios I Papachristou; Dionysios J Papachristou; Haritha Avula; Adam Slivka; David C Whitcomb
Journal:  Pancreatology       Date:  2006-04-19       Impact factor: 3.996

4.  Obesity and treatment of diabetes with glyburide may both be risk factors for acute pancreatitis.

Authors:  Kerstin B Blomgren; Anders Sundström; Gunnar Steineck; Bengt E Wiholm
Journal:  Diabetes Care       Date:  2002-02       Impact factor: 19.112

5.  Leptin is able to stimulate pancreatic enzyme secretion via activation of duodeno-pancreatic reflex and CCK release.

Authors:  K Nawrot-Porabka; J Jaworek; A Leja-Szpak; M Palonek; J Szklarczyk; S J Konturek; W W Pawlik
Journal:  J Physiol Pharmacol       Date:  2004-07       Impact factor: 3.011

6.  Leptin improves pulmonary bacterial clearance and survival in ob/ob mice during pneumococcal pneumonia.

Authors:  A Hsu; D M Aronoff; J Phipps; D Goel; P Mancuso
Journal:  Clin Exp Immunol       Date:  2007-09-05       Impact factor: 4.330

7.  Impact of chronic and acute high-fat feeding on acute experimental pancreatitis complicated by endotoxinaemia.

Authors:  R Segersvärd; M Sylván; M Lempinen; J Larsson; J Permert
Journal:  Scand J Gastroenterol       Date:  2004-01       Impact factor: 2.423

Review 8.  Acute pancreatitis.

Authors:  Jean-Louis Frossard; Michael L Steer; Catherine M Pastor
Journal:  Lancet       Date:  2008-01-12       Impact factor: 79.321

9.  Acute pancreatitis induces intrapancreatic tumor necrosis factor gene expression.

Authors:  J G Norman; G W Fink; M G Franz
Journal:  Arch Surg       Date:  1995-09

10.  Circulating mononuclear cells in the obese are in a proinflammatory state.

Authors:  Husam Ghanim; Ahmad Aljada; Deborah Hofmeyer; Tufail Syed; Priya Mohanty; Paresh Dandona
Journal:  Circulation       Date:  2004-09-13       Impact factor: 29.690

View more
  22 in total

1.  Obesity with abundant subcutaneous adipose tissue increases the risk of post-ERCP pancreatitis.

Authors:  Toshio Fujisawa; Koichi Kagawa; Kantaro Hisatomi; Kensuke Kubota; Hajime Sato; Atsushi Nakajima; Nobuyuki Matsuhashi
Journal:  J Gastroenterol       Date:  2016-01-20       Impact factor: 7.527

2.  Inhibition of the nucleotide-binding domain, leucine-rich containing family, pyrin-domain containing 3 inflammasome reduces the severity of experimentally induced acute pancreatitis in obese mice.

Authors:  Jason M York; Karla J Castellanos; Robert J Cabay; Giamila Fantuzzi
Journal:  Transl Res       Date:  2014-08-15       Impact factor: 7.012

3.  Risk factors associated with biliary pancreatitis in children.

Authors:  Michael H Ma; Harrison X Bai; Alexander J Park; Sahibzada U Latif; Pramod K Mistry; Dinesh Pashankar; Veronika S Northrup; Vineet Bhandari; Sohail Z Husain
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-05       Impact factor: 2.839

4.  Grp78 heterozygosity regulates chaperone balance in exocrine pancreas with differential response to cerulein-induced acute pancreatitis.

Authors:  Risheng Ye; Olga A Mareninova; Ernesto Barron; Miao Wang; David R Hinton; Stephen J Pandol; Amy S Lee
Journal:  Am J Pathol       Date:  2010-10-22       Impact factor: 4.307

Review 5.  The clinical significance of pancreatic steatosis.

Authors:  Mark M Smits; Erwin J M van Geenen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-02-08       Impact factor: 46.802

6.  Morbid Obesity Is Associated With Adverse Clinical Outcomes in Acute Pancreatitis: A Propensity-Matched Study.

Authors:  Somashekar G Krishna; Alice Hinton; Veeral Oza; Phil A Hart; Eric Swei; Samer El-Dika; Peter P Stanich; Hisham Hussan; Cheng Zhang; Darwin L Conwell
Journal:  Am J Gastroenterol       Date:  2015-10-20       Impact factor: 10.864

7.  Effect of obesity and decompressive laparotomy on mortality in acute pancreatitis requiring intensive care unit admission.

Authors:  Philip J B Davis; Karim M Eltawil; Bassam Abu-Wasel; Mark J Walsh; Trevor Topp; Michele Molinari
Journal:  World J Surg       Date:  2013-02       Impact factor: 3.352

8.  Obesity as a risk factor for severe acute pancreatitis patients.

Authors:  Jana Katuchova; Juraj Bober; Pavol Harbulak; Alexander Hudak; Tomas Gajdzik; Rastislav Kalanin; Jozef Radonak
Journal:  Wien Klin Wochenschr       Date:  2014-02-13       Impact factor: 1.704

Review 9.  Hormonal protection in acute pancreatitis by ghrelin, leptin and melatonin.

Authors:  Jolanta Jaworek; Stanisław Jan Konturek
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

10.  Insulin Resistance as a Novel Risk Factor for Post-ERCP Pancreatitis: A Pilot Study.

Authors:  Ali Riza Koksal; Salih Boga; Huseyin Alkim; Mehmet Bayram; Meltem Ergun; Canan Alkim
Journal:  Dig Dis Sci       Date:  2016-03-19       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.